[1]肖群霞,郑晓婷,吴春城,等.舌诊在肝硬化中的应用研究[J].医学信息,2020,33(19):21-23.[doi:10.3969/j.issn.1006-1959.2020.19.007]
　XIAO Qun-xia,ZHENG Xiao-ting,WU Chun-cheng,et al.Research Progress of Tongue Diagnosis in Cirrhosis[J].Medical Information,2020,33(19):21-23.[doi:10.3969/j.issn.1006-1959.2020.19.007]
点击复制

舌诊在肝硬化中的应用研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年19期
页码:
21-23
栏目:
综述
出版日期:
2020-10-01

文章信息/Info

Title:
Research Progress of Tongue Diagnosis in Cirrhosis
文章编号:
1006-1959（2020）19-0021-03
作者:
肖群霞; 郑晓婷; 吴春城; 唐金模; 吴耀南; 庄琳伊; 梁惠卿
福建中医药大学附属厦门中医院，福建 厦门 361009
Author(s):
XIAO Qun-xia; ZHENG Xiao-ting; WU Chun-cheng; TANG Jin-mo; WU Yao-nan; ZHUANG Lin-yi; LIANG Hui-qing
Xiamen Traditional Chinese Medicine Hospital Affiliated to Fujian University of Traditional Chinese Medicine, Xiamen 361009,Fujian,China
关键词:
舌诊; 肝硬化; 舌诊仪; 临床指标; 预后
Keywords:
Tongue diagnosis; Liver cirrhosis; Tongue diagnosis instrument; Clinical indicators;  Prognosis
分类号:
R241.25
DOI:
10.3969/j.issn.1006-1959.2020.19.007
文献标志码:
A
摘要:
肝硬化早期多无明显症状，晚期却因严重的并发症而威胁患者生命。中医的舌象与肝病严重程度有着内在的关联性，肝硬化进展可表现在舌象的变化上。因此，掌握舌象的变化规律对肝硬化的早期诊断、进行及时治疗具有重要意义。本文主要从肝硬化舌象特点、与临床指标的关系、在预后中的应用及舌诊仪的应用等方面来综述舌诊在肝硬化中的研究进展，旨在为临床治疗肝硬化提供参考。
Abstract:
In the early stage of liver cirrhosis, there are usually no obvious symptoms, but in the late stage, it threatens the patient’s life due to severe complications. The tongue picture of traditional Chinese medicine is inherently related to the severity of liver disease. The progress of liver cirrhosis can be manifested in the change of tongue picture. Therefore, mastering the changing law of tongue picture is of great significance for early diagnosis and timely treatment of liver cirrhosis. This article mainly reviews the research progress of tongue diagnosis in liver cirrhosis from the aspects of tongue characteristics, relationship with clinical indicators, application in prognosis and application of tongue diagnosis instrument, and aims to provide reference for clinical treatment of cirrhosis.

参考文献/References:

[1]刘爽,吕文良.吕文良教授调治肝硬化经验[J/OL].海南医学院学报:1-5[2020-06-14].https://doi.org/10.13210/j.cnki.jhmu.20200525.003. [2]苗静,王静,石斌豪,等.舌下络脉与肝硬化、食管胃底静脉曲张程度相关性研究[C]//第二十四次全国中西医结合肝病学术会议论文汇编.2015. [3]黄娜,唐亚平,戴芳,等.肝、胆与舌象相关性的研究[J].中华中医药杂志,2020,35(7):3388-3391. [4]周文伟,王邦才,王培劼,等.酒精性肝病患者瘀血舌象与肝功能指标的相关性研究[J].中国中医药科技,2020,27(5):673-675,718. [5]王振静,赵文霞.赵文霞教授从舌下络脉诊治代偿期肝硬化经验[J].四川中医,2012,30(1):6-7. [6]胡兴昌.舌诊与肝病辨治[J].当代医学,2009(3):153-154. [7]马素平.赵文霞教授基于“毒瘀痰虚”理论治疗肝炎肝硬化经验[J].中医研究,2015,28(11):43-46. [8]陈平.不同肝硬化舌下经脉分级与胃镜检查结果的关系分析[J].四川中医,2016,34(5):70-72. [9]张宁,邓华亮.舌下络脉与肝硬化相关性的临床观察[J].中国医学创新,2015,12(9):96-97. [10]李宁,薛晓琳,吴秀艳,等.代偿期、失代偿期肝炎肝硬化患者的舌象比较分析[J].世界中西医结合杂志,2014,9(4):371-374. [11]高毅.门脉高压性胃病中医证型及舌脉与胃镜下表现的相关性临床研究[D].甘肃中医药大学,2016. [12]宋媛媛.肝硬化患者发生自发性细菌性腹膜炎的危险因素及中医证候要素分析[D].北京中医药大学,2016. [13]金桂娴.基于数据挖掘技术对原发性肝癌中晚期舌脉特点的分析[D].山东中医药大学,2016. [14]窦智丽,吴秀艳,王天芳,等.108例肝炎肝硬化患者FibroScan56检测值与舌象的相关性分析[J].北京中医药大学学报,2018,41(10):854-858. [15]刘乐鑫,池晓玲,林姗姗,等.肝炎后肝硬化代偿期患者FibroScan肝脏硬度值与舌象变化相关性分析[J].辽宁中医药大学学报,2017,19(4):69-71. [16]田露,吴秀艳,王天芳,等.血小板计数降低的代偿期肝炎肝硬化患者中医症状分布特点研究[J].云南中医学院学报,2017,40(2):36-40. [17]樊威,李潇潇,丁江涛,等.人工智能在中医舌诊中的应用探讨[J].光明中医,2019,34(1):37-40. [18]赵研,陆小左.肝脏病理炎症纤维化分级分期与舌象的相关性[J].吉林中医药,2014,34(4):382-384. [19]宫爱民,曹玉,董秀娟,等.120例肝纤维化患者舌面象特征分析[J].世界科学技术-中医药现代化,2016,18(10):1646-1651. [20]赵丰润.乙型肝炎肝硬化代偿期患者中医干预前后舌色参数变化特点的研究[D].北京中医药大学,2015. [21]赵丽红,王天芳,薛晓琳,等.肝炎肝硬化患者舌象表现与MELD评分及其相关指标水平间相关性的探讨[J].中华中医药杂志,2014,29(5):1554-1557. [22]康梦.舌下络脉积分与肝硬化中医证型及食管胃底静脉曲张的相关性研究[D].湖南中医药大学,2018. [23]贾梓,郝建梅.舌下络脉积分与肝纤维化程度的相关性研究[J].光明中医,2016,31(21):3111-3112. [24]刘艳,李毅,许永攀,等.基于Logistic回归分析的乙肝后肝硬化中医症状组合规律研究[J].中医药导报,2017,23(21):28-32. [25]刘颖,董振华.董振华教授治疗原发性胆汁性肝硬化的经验[J].中国临床医生杂志,2015,43(1):85-86.

相似文献/References:

[1]崔 洁.凝血酶原时间与血小板检验方式对诊断肝硬化疾病的临床价值研究[J].医学信息,2018,31(04):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
　CUI Jie.Study on the Clinical Value of Prothrombin Time and Platelet Examination in the Diagnosis of Liver Cirrhosis[J].Medical Information,2018,31(19):150.[doi:10.3969/j.issn.1006-1959.2018.04.055]
[2]祁兴顺,周新苗,许向波,等.肝硬化患者应用特利加压素治疗期间发生 低钠血症的现状研究[J].医学信息,2018,31(09):1.[doi:10.3969/j.issn.1006-1959.2018.09.001]
[3]张铁彪,刘建华,马长顺.肺癌肿瘤标记物结合胸部CT检查肺结节的定性分析[J].医学信息,2022,35(10):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
　ZHANG Tie-biao,LIU Jian-hua,MA Chang-shun.Qualitative Analysis of Lung Cancer Tumor Markers Combined with Chest CT Examination of Pulmonary Nodules[J].Medical Information,2022,35(19):171.[doi:10.3969/j.issn.1006-1959.2022.10.044]
[4]赵华莹,李运泽,韦天灵,等.肝硬化合并门静脉血栓形成的危险因素分析[J].医学信息,2019,32(03):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
　ZHAO Hua-ying,LI Yun-ze,WEI Tian-ling,et al.Analysis of Risk Factors for Cirrhotic Patients with Portal Vein Thrombosis[J].Medical Information,2019,32(19):86.[doi:10.3969/j.issn.1006-1959.2019.03.026]
[5]桂志兵,汪文生.红细胞分布宽度与血小板计数比值在乙型肝炎肝硬化患者病情评估中的作用[J].医学信息,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
　GUI Zhi-bing,WANG Wen-sheng.The Role of Red Blood Cell Distribution Width and Platelet Ratio in the Evaluation of Patients with Hepatitis B Cirrhosis[J].Medical Information,2018,31(19):65.[doi:10.3969/j.issn.1006-1959.2018.20.019]
[6]王晓刚.利拉鲁肽联合胰岛素泵对2 型糖尿病合并肝硬化患者血糖代谢及肝纤维化的影响[J].医学信息,2018,31(20):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
　WANG Xiao-gang.Effects of Liraglutide Combined with Insulin Pump on Blood Glucose Metabolism and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Complicated with Cirrhosis[J].Medical Information,2018,31(19):136.[doi:10.3969/j.issn.1006-1959.2018.20.041]
[7]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(19):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[8]姜海燕.双歧杆菌四联活菌治疗对肝硬化患者肝功能、细胞因子及肠道菌群的影响[J].医学信息,2022,35(12):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
　JIANG Hai-yan.Effect of Quadruple Viable Bifidobacterium Treatment on Liver Function, Cytokines and Intestinal Flora in Patients with Liver Cirrhosis[J].Medical Information,2022,35(19):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
[9]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Medical Information,2019,32(19):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[10]陈 杰.左旋肉碱治疗肝硬化并显性肝性脑病的效果观察[J].医学信息,2019,32(14):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]
　CHEN Jie.Effect of L-carnitine on Liver Cirrhosis and Dominant Hepatic Encephalopathy[J].Medical Information,2019,32(19):153.[doi:10.3969/j.issn.1006-1959.2019.14.051]

更新日期/Last Update: 1900-01-01